Hi Quip
Firstly, links are below to three previous posts on Soleno.
Yes Soleno’s market cap increased dramatically in September this year (it has gone from US$44m to US$1.2 bn) because its second Phase 3 trial met its primary endpoint and Soleno is now preparing to submit an NDA to the FDA.
Like Acadia’s trial, the focus is on hyperphagia associated with Prader-Willi syndrome.
We won’t see a 2000% rise when our PWS results come out because it is Phase 2 only, not a registrational trial, and because our market cap is already well advanced from $44m!
Our orphan drug status remains – there can be multiple orphan drugs for the same indication. Orphan drug status protects you from generic competition for 7 years but not from competition from other drugs.
https://hotcopper.com.au/threads/phase2-prader-willi-syndrome-start.7407217/page-16?post_id=70059494
https://hotcopper.com.au/threads/phase2-prader-willi-syndrome-start.7407217/page-15?post_id=70052057
https://hotcopper.com.au/threads/share-price.6359591/page-640?post_id=58554923
Neuren Media and Analyst Coverage, page-640
-
- There are more pages in this discussion • 560 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.27 |
Change
0.650(3.15%) |
Mkt cap ! $2.718B | |||
| Open | High | Low | Value | Volume |
| $20.84 | $21.56 | $20.76 | $7.760M | 364.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1378 | $21.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.29 | 218 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |